CPRC
MLSS icon

Consolidated Portfolio Review Corp’s Milestone Scientific MLSS Stock Holding History

Consolidated Portfolio Review Corp’s Portfolio MLSS Stock Details MLSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14,651
Closed -$6.66K – 257
2025
Q3 		$6.66K Hold
14,651
– – ﹤0.01% 451
2025
Q2 		$9.32K Buy
14,651
+2,551
+21% +$2.34K ﹤0.01% 444
2025
Q1 		$11.3K Buy
+12,100
New +$13.3K ﹤0.01% 377

Other funds holding MLSS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CIC
Carnegie Investment Counsel Pepper Pike, Ohio $5.13B AUM 22.98% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.2B AUM 19.68% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Consolidated Portfolio Review Corp's MLSS Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of Milestone Scientific (MLSS) in Q4 2025, closing a stake of 14,651 shares — an estimated $6.66K sold.

Consolidated Portfolio Review Corp first reported a position in MLSS in Q1 2025 and held it in 3 quarters. The position peaked at $11.3K in Q1 2025. 31 funds tracked by Wall St. Rank hold MLSS as of Q4 2025.

  • Consolidated Portfolio Review Corp reported no remaining Milestone Scientific position as of Q4 2025 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 14,651 Milestone Scientific shares in Q4 2025, an estimated $6.66K.
  • Consolidated Portfolio Review Corp first reported a position in Milestone Scientific in Q1 2025 and held it in 3 quarters.
  • Consolidated Portfolio Review Corp's Milestone Scientific position peaked at $11.3K in Q1 2025.
  • 31 funds tracked by Wall St. Rank held Milestone Scientific as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.